SCHEMBL4314928

SCHEMBL4314928

CCCS(=O)(=O)NC(C)Oc1ccc(/C=C/c2n[nH]c3ccccc23)c([N+](=O)[O-])c1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.38
LMNA P02545 7/20 0.38
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
ALDH1A1 P00352 5/20 0.38
NPC1 O15118 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
GAA P10253 3/20 0.38
HTT P42858 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 3/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.31
CASP3 P42574 1/20 0.30
SENP8 Q96LD8 1/20 0.30
SENP7 Q9BQF6 1/20 0.30
SENP6 Q9GZR1 1/20 0.30
AURKA O14965 1/20 0.30
AURKB Q96GD4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4314935 1.00 MAPT (0.38) MAPTLMNAMEN1KMT2AALDH1A1
SCHEMBL4314939 0.84 KMT2A (0.38) MAPTLMNAMEN1KMT2AALDH1A1
SCHEMBL4314932 0.84 KMT2A (0.38) MAPTLMNAMEN1KMT2AALDH1A1
SCHEMBL4321984 0.77 MAPT (0.41) MAPTLMNAMEN1KMT2AALDH1A1
SCHEMBL4321978 0.77 MAPT (0.41) MAPTLMNAMEN1KMT2AALDH1A1
SCHEMBL4309120 0.77 MAPT (0.45) MAPTLMNAMEN1KMT2AALDH1A1
SCHEMBL4309124 0.77 MAPT (0.45) MAPTLMNAMEN1KMT2AALDH1A1
SCHEMBL4308261 0.77 MAPT (0.41) MAPTLMNAMEN1KMT2AALDH1A1
SCHEMBL4308256 0.77 MAPT (0.41) MAPTLMNAMEN1KMT2AALDH1A1
SCHEMBL4311757 0.76 MAPT (0.60) MAPTLMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 MAPT 4175/4885LMNA 4397/4885MEN1 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.